📰 Gray Cap News
Page 2 - Gray Cap News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gray Cap. Real-time updates on events, politics, business and more.
April 14, 2022
Data from a subanalysis of 30 sera from a Phase 2/3 clinical trial of children 5 through 11 years of age show a 36-fold increase in SARS-CoV-2 Omicron neutralizing titers following a booster (third)
March 29, 2022
FDA also authorizes second booster dose for individuals 12 years of age and older who have certain kinds of immunocompromise Second booster dose is intended to offer increased protection against
February 11, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to extend their rolling submission to the U.S. Food and Drug Administration (FDA) seeking to amend the Emergency Use Authorization
February 1, 2022
With pediatric COVID-19 cases surpassing 10 million and at the request of the FDA, the companies have submitted available data on the safety and efficacy of two 3 µg doses as part of a three-dose
December 20, 2021
European Commission exercise part of its option for over 200 million additional doses to be delivered in 2022 These doses are in addition to the 450 million doses already planned for delivery
December 9, 2021
First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that
October 29, 2021
Emergency Use Authorization (EUA) is supported by clinical data showing a favorable safety profile and high vaccine efficacy of 90.7% in children 5 through 11 years of age during a period when Delta